One year in review
Systemic sclerosis: one year in review 2022
G. Lepri1, M. Orlandi2, M. Di Battista3, G. De Mattia4, M. Da Rio5, V. Codullo6, S. Guiducci7, A. Della Rossa8
- Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Italy.
- Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Fondazione IRCS Policlinico San Matteo, Pavia, Italy.
- Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. a.dellarossa@ao-pisa.toscana.it
CER15998
2022 Vol.40, N°10
PI 1911, PF 1920
One year in review
Free to view
(click on article PDF icon to read the article)
PMID: 36135958 [PubMed]
Received: 28/06/2022
Accepted : 29/06/2022
In Press: 21/09/2022
Published: 17/10/2022
Abstract
Systemic sclerosis (SSc) is an autoimmune disease characterised by microvasculopathy, immune dysregulation, and skin and visceral organ fibrosis. Every year novel insights into the pathogenesis, organ involvement and treatment of this severe disease are published in the scientific community. In this review we report an overview of some of the most relevant contributions published in 2021.
